Thermo Fisher opens manufacturing site for COVID-19 viral transport media

By The Science Advisory Board staff writers

August 28, 2020 -- Thermo Fisher Scientific has opened its new $40 million facility in Lenexa, KS, dedicated to viral transport media (VTM) production. The groundbreaking ceremony was held on August 28.

The facility created more than 300 jobs and added 120,000 sq ft of manufacturing capacity. The company also announced that they will expand the site to meet the expected sustained demand for COVID-19 testing.

The new facility in Lenexa, KS has enabled production to scale from 50,000 viral transport media tubes to more than 8 million per week. Image courtesy of Thermo Fisher Scientific.

In May, the company received a contract from the U.S. government to provide a significant quantity of highly specialized VTM for COVID-19 sample collection. The VTM is dispensed into plastic tubes that are used to safely collect and transport clinical specimens containing viruses. Thermo Fisher has quickly ramped up production in Lenexa from 50,000 units per week to now more than 8 million per week.

Copyright © 2020
To access all The ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
I have read and agree to the privacy policy and terms of service and wish to opt-in for

Already have an account? Sign in here